Long-term diabetic response to gastric bypass

Journal of Surgical Research

Volumn 190, Issue 2, 2014, Pages 498-503

  Davies, Stephen W ^a   Efird, Jimmy T ^b   Guidry, Christopher A ^a   Penn, Rachel I ^c   Sawyer, Robert G ^a   Schirmer, Bruce D ^a   Hallowell, Peter T ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Diabetes cure; Gastric bypass; Long term follow up

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH BYPASS; TREATMENT RESPONSE; WEIGHT REDUCTION;

DIABETES; DIABETES CURE; GASTRIC BYPASS; LONG-TERM FOLLOW-UP;

ADULT; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84904258625     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.01.047     Document Type: Article

References (42)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. United States Department of Health and Human Services. Centers for disease control and prevention. National Center for Health Statistics. 2012. Available from: http://www.cdc.gov/nchs/data/databriefs/db82. pdf. Accessed on 10/12/2013.
2. United States Department of Health and Human Services. 2020 Leading health indicators available from: http://www.healthypeople.gov/2020/LHI/ 2020indicators.aspx. Accessed on 10/12/2013.
3. Centers for Disease Control and Prevention. Adult obesity. Available from: http://www.cdc.gov/vitalsigns/AdultObesity/index.html. Accessed on 10/12/2013.
4. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. United States Department of Health and Human Services. 2011. Available from: www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf. Accessed on 10/13/2013.
5. A.J. Garber Obesity and type 2 diabetes: which patients are at risk? Diabetes Obes Metab 14 2012 399
6. National Heart Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. 1998. Available from: www.nhlbi.nih.gov/guidelines/obesity/ ob-gdlns.pdf. Accessed on 10/13/2013.
7. D. Edholm, F. Svensson, I. Naslund, F.A. Karlsson, E. Rask, and M. Sundbom Long-term results 11 years after primary gastric bypass in 384 patients Surg Obes Relat Dis 9 2013 708
8. W.J. Pories, M.S. Swanson, and K.G. MacDonald et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 1995 339 discussion 50-2
9. W.J. Pories, K.G. MacDonald Jr., and E.G. Flickinger et al. Is type II diabetes mellitus (Niddm) a surgical disease? Ann Surg 215 1992 633 discussion 43
10. L.M. Carlsson, M. Peltonen, and S. Ahlin et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects The New Engl J Med 367 2012 695
11. M. Neovius, K. Narbro, and C. Keating et al. Health care use during 20 years following bariatric surgery JAMA: J Am Med Assoc 308 2012 1132
12. L. Sjostrom Review of the key results from the Swedish obese subjects (Sos) trial - a prospective controlled intervention study of bariatric surgery J Intern Med 273 2013 219
13. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515
14. A. Dempster, N. Laird, and D. Rubin Maximum likelihood form incomplete data via the Em algorithm JR Stat Soc Ser B Stat Methodol 39 1977 1
15. J. Ware, D. Harrington, D. Hunter, and R. D'Agostino Missing data The New Engl J Med 367 2012 1353
16. R.J. Little, R. D'Agostino, and M.L. Cohen et al. The prevention and treatment of missing data in clinical trials The New Engl J Med 367 2012 1355
17. J.T. Efird, S. Lea, A. Toland, and C.J. Phillips Informational odds ratio: a useful measure of epidemiologic association in environment exposure studies Environ Health Insights 6 2012 17
18. K. Wickremesekera, G. Miller, T.D. Naotunne, G. Knowles, and R.S. Stubbs Loss of insulin resistance after Roux-En-Y gastric bypass surgery: a time course study Obes Surg 15 2005 474
19. P.R. Schauer, S.R. Kashyap, and K. Wolski et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes The New Engl J Med 366 2012 1567
20. T.C. Hall, M.G. Pellen, P.C. Sedman, and P.K. Jain Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-En-Y gastric bypass surgery for obesity Obes Surg 20 2010 1245
21. N. Hamza, M.H. Abbas, A. Darwish, Z. Shafeek, J. New, and B.J. Ammori Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass Surg Obes Relat Dis 7 2011 691
22. S. Ikramuddin, J. Korner, and W.J. Lee et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial JAMA: J Am Med Assoc 309 2013 2240
23. R. Morinigo, A.M. Lacy, R. Casamitjana, S. Delgado, R. Gomis, and J. Vidal Glp-1 and changes in glucose Tolerance following gastric bypass surgery in morbidly obese subjects Obes Surg 16 2006 1594
24. G. Mingrone, S. Panunzi, and A. De Gaetano et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes The New Engl J Med 366 2012 1577
25. C.M. Yamaguchi, J. Faintuch, S.Y. Hayashi, J.J. Faintuch, and I. Cecconello Refractory and new-onset diabetes more than 5 Years after gastric bypass for morbid obesity Surg Endosc 26 2012 2843
26. T.D. Adams, L.E. Davidson, and S.E. Litwin et al. Health benefits of gastric bypass surgery after 6 years JAMA: J Am Med Assoc 308 2012 1122
27. R.V. Cohen, J.C. Pinheiro, C.A. Schiavon, J.E. Salles, B.L. Wajchenberg, and D.E. Cummings Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity Diabetes Care 35 2012 1420
28. D.E. Arterburn, A. Bogart, and N.E. Sherwood et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass Obes Surg 23 2013 93
29. J.B. Dixon, D.K. Murphy, J.E. Segel, and E.A. Finkelstein Impact of laparoscopic adjustable gastric banding on type 2 diabetes Obes Rev 13 2012 57
30. J.P. Thaler, and D.E. Cummings Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery Endocrinology 150 2009 2518
31. D.E. Cummings Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery Int J Obes 33 Suppl 1 2009 S33
32. A. Chronaiou, M. Tsoli, I. Kehagias, M. Leotsinidis, F. Kalfarentzos, and T.K. Alexandrides Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial Obes Surg 22 2012 1761
33. L.M. Beckman, T.R. Beckman, and C.P. Earthman Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review J Am Diet Assoc 110 2010 571
34. A. Jimenez, R. Casamitjana, L. Flores, S. Delgado, A. Lacy, and J. Vidal Glp-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese Subjects Ann Surg 257 2013 894
35. J. Vidal, J. Nicolau, and F. Romero et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects The J Clin Endocrinol Metab 94 2009 884
36. N.B. Jorgensen, S.H. Jacobsen, and C. Dirksen et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance Am J Physiol Endocrinol Metab 303 2012 E122
37. F. Rubino, P.R. Schauer, L.M. Kaplan, and D.E. Cummings Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action Annu Rev Med 61 2010 393
38. A.A. Gumbs, I.M. Modlin, and G.H. Ballantyne Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss Obes Surg 15 2005 462
39. H.J. Kissler, and U. Settmacher Bariatric surgery to treat obesity Semin Nephrol 33 2013 75
40. S.E. Greenway, F.L. Greenway 3rd, and S. Klein Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 2002 1109
41. F. Rubino, and M. Gagner Potential of surgery for curing type 2 diabetes mellitus Ann Surg 236 2002 554
42. R.I. Meijer, B.A. van Wagensveld, C.E. Siegert, E.C. Eringa, E.H. Serne, and Y.M. Smulders Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review Arch Surg 146 2011 744